Literature DB >> 12744029

[Advantages and disadvantages of ECG diagnosis in left ventricular hypertrophy].

R Cífková1.   

Abstract

Left ventricular hypertrophy (LVH) develops as a response to press or volume overload of the left ventricle. It is encountered in systemic hypertension, aortal stenosis and aortal insufficiency, mitral valve insufficiency, some congenital cardiac defects and hypertrophic obstructive cardiomyopathy. The most frequent cause of LVH in the adult population is hypertension. Prevalence of left ventricular hypertrophy in hypertensive individuals varies considerably, depending on the applied diagnostic method and characteristic of the group of hypertonic subjects. The presence of ECG signs of LVH is an infaust prognostic sign which at any level of blood pressure causes marked deterioration of the patient's prognosis. Classical ECG criteria for detection of LVH have a satisfactory specificity but low sensitivity. The sensitivity declines dramatically in the presence of obesity. The most sensitive but least specific criterium is high voltage in the precordial leads. The accuracy of ECG diagnosis of LVH improves considerably by multiplying the voltage by the duration of the QRS complex. Most probably the best results are obtained by Cornell's product. Falsely positive ECG signs of LVH (most frequently voltage criteria) are present in asthenic subjects. The author describes the case-history of a patient with hypertension who develops an ECG tracing imitating an infarction of the posterior wall and left ventricular hypertrophy with overburdening.

Entities:  

Mesh:

Year:  2002        PMID: 12744029

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  2 in total

1.  Cardiorespiratory system monitoring using a developed acoustic sensor.

Authors:  Reza Abbasi-Kesbi; Atefeh Valipour; Khadije Imani
Journal:  Healthc Technol Lett       Date:  2018-01-12

Review 2.  Predictive value of electrocardiographic markers in children with dilated cardiomyopathy.

Authors:  Miao Wang; Yi Xu; Shuo Wang; Ting Zhao; Hong Cai; Yuwen Wang; Runmei Zou; Cheng Wang
Journal:  Front Pediatr       Date:  2022-08-23       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.